ERIN RIZZO: Open Payments
NPI 1912429051 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 23 payments from 12 companies in 2025. Trend: 2023 $444 · 2024 $2,085 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 1 | $129 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| PFIZER INC. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $46 |
| Amgen Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
Products named: FFRct, LEQVIO, ELIQUIS, AMVUTTRA, FUROSCIX, FARXIGA, REPATHA, CAMZYOS.
Industry payments across IL — which companies pay providers there.
